Correlation between telomere length and brain age

A study by researchers at the Max Planck Institute for Human Cognitive and Brain Sciences has shown that when telomeres change in length, changes happen in the structure of our brains.

Telomeres are protective genetic ‘caps’ found on the ends of our chromosomes. Like the plastic aglets on the ends of shoelaces, telomeres prevent our chromosomes from fraying or from sticking to each other, but they also play a role in the aging process.

Longevity.Technology: Telomeres are somewhat of a paradox. Long ones indicate a lower risk of some metabolic diseases and younger cells, but they can also predict a greater risk of some cancers. They clearly correlate to aging, but whether lengthening them through genetic or lifestyle intervention can delay or reverse aging still remains to be seen.

The TRL score for this Longevity.Technology domain is currently set at: ‘Principles are demonstrated through experimentation.’

The TRL score for the technology addressed in this article is:  ‘Principles are demonstrated through experimentation.’

When a cell replicates its genetic material and divides, a few of the genetic sequence of instructional ‘letters’ at the end of each chromosome gets missed off. To avoid key genetic material being lost in the division process, the telomeres are made of the same sequence of nucleotides repeated again and again, so when one of those sequences doesn’t make it through the division process, no harm is done. The telomeres can’t shorten indefinitely, though, and once they reached a certain length, cell division stops and the cell either dies or becomes senescent (inactive and unable to repair itself). Uncontrolled cell division causes cancer, so telomeres are vital for our survival.

As well as the natural shortening process, telomeres can be shortened by genetics and unhealthy lifestyle choices, or lengthened with enzymes and a healthy diet and exercise. The Max Planck Institute team wanted to investigate whether changes in telomere length were linked to biological aging.

Researcher Lara Puhlmann of the Research Group “Social Stress and Family Health” explained: “To explore whether a short-term change in telomere length, after only a few months, might actually be associated with changes in a person’s biological age, we linked it to another biomarker of aging and health: brain structure [1].”

Participants in the study underwent four MRI examinations, each spaced three months apart. They also provided blood samples on the same dates and by examining the DNA of leukocytes from the blood samples, the research team was able to calculate telomere length by using a polymerase chain reaction. The outer layer of grey matter in our brains – the cerebral cortex – thins with age, so the team used the MRI scans to calculate the thickness of the cerebral cortex of each study participant.

Puhlmann commented on the team’s findings: “Across systems, our biological aging appears to change more quickly than we thought. Indices of aging can vary together significantly in just three months [2].”

The researchers found that lengthening telomeres were associated with thickening cortexes while shortening telomeres were associated with reductions in the amount of grey matter, with some similarities to dementia-sufferers exhibited. These changes occurred in an area of the brain called the precuneus, which is a central metabolic and connectional hub.

Although the results suggest that both changes in grey matter and telomere length might reflect changes in the body’s health and biological age, it is only a jumping off point with no evidence at this time to suggest one change causes the other, merely that there is a correlation with the changes in the body.

“We do not know, for example, which biological mechanism underlies the short-term changes in telomere length”, explained Puhlmann, “or whether the short-term changes really have a longer-term effect on health [3].”

Check out our exclusive interview with Lara Puhlmann here.

[1] https://neurosciencenews.com/cellular-aging-brain-structure-14994/
[2] https://www.sciencedaily.com/releases/2019/09/190927103248.htm
[3] https://bit.ly/33ydLL6

Image credit: Courtesy of the Max Planck Institute for Human Cognitive and Brain Sciences
Eleanor Garth
Staff Writer and Community Manager Following a degree in Classics, Eleanor organised biomedical engineering conferences and provided research support at Imperial College London and various London hospitals, before working as a science and medicine journalist.

Latest articles

VC enters Longevity market with K4Connect deal

We talk with VC investor Forte Ventures about its first foray into AgeTech, COVID-19 and the Longevity investment opportunity. Longevity agetech company K4Connect has announced...

Challenging the one drug/one disease model

A new paper supports the targeting of aging processes, rather than just one disease, to improve Longevity outcomes. Multimorbidity is a challenge for Longevity; defined...

Robotics and AI combine for new therapeutics discovery

Insilico Medicine and Arctoris announce robotics/AI partnership to focus on COVID-19 inhibitors that could have wide-reaching benefits for Longevity. Two companies have joined forces in...

The results are in: sharing our Longevity investment survey

There is rapidly-increasing activity in both the research and the investment communities that focus on Longevity; this survey gets into the details. The global Longevity...